Matthew Pauls insider trades: Pelthos Therapeutics (PTHS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
and 2 more companies
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | PTHS | ↓ Sell | 786 | $21.00 | $17K | Direct | Oct 6, 2026 (4d) |
| Jul 2, 2026 | PTHS | ↓ Sell | 786 | $26.16 | $21K | Direct | Jul 7, 2026 (5d) |
| Apr 2, 2026 | PTHS | ↓ Sell | 786 | $20.92 | $16K | Direct | Apr 6, 2026 (4d) |
| Mar 28, 2025 | SLNO | ↓ Sell | 5,937 | $71.55 | $425K | Direct | Mar 31, 2025 (3d) |
| Dec 16, 2024 | SVRA | ↓ Sell | 54,702 | $3.31 | $181K | Direct | Dec 16, 2024 (0d) |
| Dec 28, 2023 | SVRA | ↓ Sell | 84,000 | $4.71 | $396K | Direct | Dec 29, 2023 (1d) |
| Dec 8, 2021 | SVRA | ↑ Buy | 6,500 | $1.06 | $7K | Direct | Dec 8, 2021 (0d) |
| Dec 2, 2021 | SVRA | ↑ Buy | 10,000 | $1.10 | $11K | Direct | Dec 2, 2021 (0d) |
| Nov 19, 2021 | SVRA | ↑ Buy | 22,150 | $1.10 | $24K | Direct | Nov 22, 2021 (3d) |
| Aug 18, 2021 | SVRA | ↑ Buy | 26,900 | $1.18 | $32K | Direct | Aug 18, 2021 (0d) |
| May 21, 2021 | SVRA | ↑ Buy | 10,000 | $1.63 | $16K | Direct | May 24, 2021 (3d) |
| Apr 19, 2021 | SVRA | ↑ Buy10b5-1 | 27,400 | $1.82 | $50K | Direct | Apr 19, 2021 (0d) |
| Mar 22, 2021 | SVRA | ↑ Buy10b5-1 | 24,100 | $2.07 | $50K | Direct | Mar 22, 2021 (0d) |
| Feb 22, 2021 | SVRA | ↑ Buy10b5-1 | 28,700 | $1.74 | $50K | Direct | Feb 23, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PTHS insiders
Open-market trades in the last 12 months
About Matthew Pauls's insider trades
Matthew Pauls is a director at Pelthos Therapeutics (PTHS). Since Feb 22, 2021, Matthew has reported 8 open-market purchases worth $240K and 6 sales worth $1.1M on SEC Form 4. In the last 12 months: 3 sales ($54K).
Their filings also include grants and awards (26 filings), shares withheld for taxes (6 filings), gifts (4 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PTHS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.